Clinical trial
Study of Sildenafil in Advanced Heart Failure.
NCT00309790 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00309790 |
|---|---|
| Title | Study of Sildenafil in Advanced Heart Failure. |
| Official title | Phase 3 Study of the Effects of Chronic Sildenafil Citrate Therapy on Exercise Tolerance and Hemodynamics in Patients With Advanced Heart Failure. |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure |
| Intervention type | Drug |
| Interventions | sildenafil |
| Enrollment | 40 |
| Start date | May 1, 2003 |
| Completion | Mar 1, 2006 |
| First posted | Apr 3, 2006 |
| Last update posted | Aug 11, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: